0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Live Cytomegalovirus Vaccination of Renal Transplant Candidates: A Preliminary Trial

JOHN P. GLAZER, M.D.; HARVEY M. FRIEDMAN, M.D.; ROBERT A. GROSSMAN, M.D.; STUART E. STARR, M.D.; CLYDE F. BARKER, M.D.; LEONARD J. PERLOFF, M.D.; ENG-SHANG HUANG, Ph.D.; and STANLEY A. PLOTKIN, M.D.
[+] Article and Author Information

This study was supported by grant AI-14927 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, and by a grant from Merck and Co., Inc., West Point, Pennsylvania.

▸Requests for reprints should be addressed to John P. Glazer, M.D.; Children's Hospital, 700 Children's Drive; Columbus, OH 43205.


Philadelphia, Pennsylvania; and Chapel Hill, North Carolina


Ann Intern Med. 1979;91(5):676-683. doi:10.7326/0003-4819-91-5-676
Text Size: A A A

Significant morbidity and mortality are associated with primary cytomegalovirus infections in renal-transplant recipients. In the hope that immunity to cytomegalovirus could safely be established before transplantation, we vaccinated 12 seronegative renal-transplant candidates with the Towne 125 strain of live human cytomegalovirus. Before transplantation, there were no significant reactions except for erythema and induration at the site of inoculation. All vaccinees seroconverted, and the three patients tested acquired a cytomegalovirus-specific cellular immune response. Ten vaccinees underwent transplantation: Nine have completed at least 3 months of follow-up, and eight retain functioning allografts up to 1 year later. Although cytomegalovirus was isolated from six patients after transplantation, the restriction endonuclease patterns of the viral DNA of four of these isolates differed significantly from those of the vaccine strain. Therefore, it appears that the vaccine strain did not become latent in the host, at least in a form that could be reactivated.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Viral infections in transplant recipients. Minerva Med 2009;100(6):479-501.
Post-transplant infections: An ounce of prevention. Indian J Nephrol 2010;20(4):171-8.
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)